Patient guides · care in China
Targeted Cancer Therapy in China: tumour biomarkers, previous drugs and treatment access. Prepare for specialist review.
Prepare for a first in-person targeted cancer therapy discussion in China: which biomarker, drug and monitoring questions to bring and what to confirm.
How to hand over records of existing conditions, tumour biomarkers and previous drugs when a China centre assesses targeted cancer therapy suitability.
Confirm the medical and travel steps for targeted cancer therapy in China as two separate timelines, with clinical decisions in writing before booking.
How overseas patients can discuss targeted cancer therapy access in China: confirm the drug, biomarker context, case assessment and monitoring plan.
Which records matter for targeted cancer therapy in China, who to request them from, and how gaps affect the next step before you travel.
Why tumour biomarker results shape targeted cancer therapy assessment in China, what records to prepare, and what to confirm with the treating centre.
Get a written follow-up plan for targeted cancer therapy in China: record reviews, records, contacts and who is responsible for each step.
Before consenting to targeted cancer therapy in China, confirm the drug, biomarker evidence, monitoring plan and what your written estimate covers.
What previous tests and a new assessment each answer for targeted cancer therapy in China, and what to confirm with the treating centre before travelling.
How to ask a Chinese cancer centre about targeted therapy risks, alternatives, biomarker context and how ongoing treatment would continue.
Understand what may sit outside a written targeted therapy estimate in China, and how to confirm scope, authorisation and ongoing supply before you commit.
Already had targeted cancer drugs? Learn what records to prepare, what to ask a Chinese centre about prior treatment, and how to request a case review.
How to describe previous cancer treatment results for targeted therapy review in China: drug names, biomarker reports, response and current status.
New biomarker or scan results can change a targeted therapy plan. Learn what to reconfirm with a China centre before any treatment decision.
Confirm the department, campus and appointment type for targeted cancer therapy in China before travel, using your biomarker and drug records.
What targeted cancer therapy can and cannot address, why biomarker and prior-treatment records matter, and what to confirm with a China centre.
How to exchange biomarker results, drug history and treatment questions between your home oncology team and a hospital in China before targeted therapy.
How overseas patients can plan targeted cancer treatment in China while keeping care abroad: records, questions, trip feasibility and contingencies.
A biomarker result identifies a molecular feature but does not confirm a drug, dose or access in China.
Prepare biomarker and treatment records for a targeted therapy review in China, and learn what the specialist still needs to confirm.
How to prepare drug, dose and safety records after targeted therapy in China so your home oncologist can review them and decide your next step.
Compare targeted therapy estimates in China by checking the exact drug, dose and monitoring scope against your treatment records.